LPL Financial
KRYS icon

LPL Financial’s Krystal Biotech KRYS Stock Holding History

LPL Financial’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
4,317
+2,552
+145% +$762K ﹤0.01% 3990
2026
Q1 		$456K Buy
1,765
+611
+53% +$163K ﹤0.01% 4846
2025
Q4 		$285K Buy
+1,154
New +$243K ﹤0.01% 5184
2025
Q2 		– Sell
-1,660
Closed -$299K – 5633
2025
Q1 		$299K Sell
1,660
-1,286
-44% -$216K ﹤0.01% 4574
2024
Q4 		$462K Buy
2,946
+1,799
+157% +$319K ﹤0.01% 4168
2024
Q3 		$209K Buy
+1,147
New +$221K ﹤0.01% 4697
2024
Q1 		– Sell
-1,655
Closed -$205K – 4982
2023
Q4 		$205K Buy
+1,655
New +$184K ﹤0.01% 4376

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

LPL Financial's KRYS Position: Q2 2026 in Review

LPL Financial increased its Krystal Biotech (KRYS) stake by 145% in Q2 2026, buying an estimated $762K and bringing the position to 4,317 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3990.

LPL Financial first reported a position in KRYS in Q4 2023 and has held it in 7 quarters since. 191 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • LPL Financial held 4,317 shares of Krystal Biotech worth $1.6M as of Q2 2026.
  • LPL Financial bought 2,552 Krystal Biotech shares in Q2 2026, an estimated $762K.
  • Krystal Biotech made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3990 holding.
  • LPL Financial first reported a position in Krystal Biotech in Q4 2023 and has held it in 7 quarters since.
  • 191 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.